Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.

NCT03325296 is registered in ClinicalTrials.gov with LEO Pharma as lead sponsor.

NCT NCT03325296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03325296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata.
Lead sponsor
LEO Pharma
Phase
Phase 2
Overall status
Terminated
Start date
October 30, 2017
Completion date
May 16, 2018
Enrollment
13 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata